News

Opportunity to join European Medicines Agency committee

The European Medicines Agency is looking for two patient representatives to join its medicines approval committee.

16/11/2026

The European Medicines Agency (EMA) evaluates and supervises medicines across the EU. It is seeking two patient representatives to join its Committee for Medicinal Products for Human Use (CHMP) for an initial 12-month pilot period, which may be renewed. You would be supported to participate in meetings and the authorisation process. Payment for involvement is available.

 

To be eligible to apply, you:

  • must be a member of an organisation that fulfils EMA eligibility criteria or a current member of an EMA committee (COMP, CAT, PDCO or PRAC) or Management Board nominated by the European Commission.
  • should have proven experience at European medicines regulatory level (e.g. participation in PCWP, HCPWP, medicine-related activities or other relevant fora).
  • should have a good understanding of the work and time implications of the tasks to be undertaken (see CHMP).
  • should commit to participate regularly in the meetings of the CHMP and to contribute as expected to the different activities.

 

ELF will nominate two patients to the committee. If you would like to apply for nomination, please contact daniel.beever@europeanlung.org by 27 November 2026, providing the following information:

  • A curriculum vitae (CV)
  • A letter of motivation that includes a brief résumé, addressing the selection criteria above.

Any questions can be directed to the same address.